Masanaru Sawada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masanaru Sawada has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Yasuo Okumura
Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
14 shared publications - Koichi Nagashima
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
13 shared publications - Shu Hirata
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
13 shared publications - Ryuta Watanabe
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
12 shared publications Naoto Otsuka
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan
10 shared publications- Yuji Wakamatsu
Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610
10 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (6)
Posterior Pulmonary Vein Isolation Lesion Spacing and Left Atrial Posterior Wall Narrowing During Pulsed Field Ablation
Background: Left atrial posterior wall (LAPW) narrowing after excessive extension of bilateral pulmonary vein isolation (PVI) lines during pulsed field ablation (PFA) may create a proarrhythmic substrate. The CARTO 3‐integrated variable‐loop circular catheter (VLCC) provides real‐time tissue proximity indication (TPI) and ablation‐tag location, but their relationship with LAPW narrowing remains unclear. Therefore, we evaluated associations of TPI status and inter‐tag distance (ITD) with acute LAPW narrowing and whether an ITD‐guided workflow was associated with LAPW preservation. Methods: Fifty‐two retrospective and 27 prospective atrial fibrillation patients underwent PFA using a VLCC. In the retrospective phase, we evaluated the association between ITD, measured using TPI‐positive tags and all tags, and LAPW narrowing (< 10 mm) and derived a cutoff. In the prospective phase, the ITD‐guided workflow was applied, and we assessed residual LAPW band width. Results: In the retrospective phase, both TPI‐positive‐tag ITD and all‐tag ITD correlated with LAPW band width ( r = 0.63 and 0.70, respectively; both p < 0.001). All‐tag ITD showed a numerically higher AUC for LAPW narrowing than TPI‐positive‐tag ITD (0.869 vs. 0.795; p = 0.099), with an optimal all‐tag ITD cutoff of 16.5 mm. In the prospective phase incorporating the all‐tag ITD cutoff, residual LAPW band widths were wider at the roof (19.4 ± 7.9 vs. 25.1 ± 7.1 mm; p = 0.002) and carina (13.6 ± 7.1 vs. 20.8 ± 8.0 mm; p < 0.001) than in the retrospective phase. Conclusions: An all‐tag ITD‐guided workflow was associated with greater preservation of the residual LAPW band width.
- 28 October 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (6)
Open AccessPosterior Pulmonary Vein Isolation Lesion Spacing and Left Atrial Posterior Wall Narrowing During Pulsed Field Ablation
Background: Left atrial posterior wall (LAPW) narrowing after excessive extension of bilateral pulmonary vein isolation (PVI) lines during pulsed field ablation (PFA) may create a proarrhythmic substrate. The CARTO 3‐integrated variable‐loop circular catheter (VLCC) provides real‐time tissue proximity indication (TPI) and ablation‐tag location, but their relationship with LAPW narrowing remains unclear. Therefore, we evaluated associations of TPI status and inter‐tag distance (ITD) with acute LAPW narrowing and whether an ITD‐guided workflow was associated with LAPW preservation. Methods: Fifty‐two retrospective and 27 prospective atrial fibrillation patients underwent PFA using a VLCC. In the retrospective phase, we evaluated the association between ITD, measured using TPI‐positive tags and all tags, and LAPW narrowing (< 10 mm) and derived a cutoff. In the prospective phase, the ITD‐guided workflow was applied, and we assessed residual LAPW band width. Results: In the retrospective phase, both TPI‐positive‐tag ITD and all‐tag ITD correlated with LAPW band width ( r = 0.63 and 0.70, respectively; both p < 0.001). All‐tag ITD showed a numerically higher AUC for LAPW narrowing than TPI‐positive‐tag ITD (0.869 vs. 0.795; p = 0.099), with an optimal all‐tag ITD cutoff of 16.5 mm. In the prospective phase incorporating the all‐tag ITD cutoff, residual LAPW band widths were wider at the roof (19.4 ± 7.9 vs. 25.1 ± 7.1 mm; p = 0.002) and carina (13.6 ± 7.1 vs. 20.8 ± 8.0 mm; p < 0.001) than in the retrospective phase. Conclusions: An all‐tag ITD‐guided workflow was associated with greater preservation of the residual LAPW band width.
- Open Access
- 21 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Irrigation-dependent acute ganglionated plexus modulation during variable-loop pulsed field ablation
Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.
- 21 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Open AccessIrrigation-dependent acute ganglionated plexus modulation during variable-loop pulsed field ablation
Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- Open Access
- 19 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Clinical Significance of Patient Disease Awareness in Atrial Fibrillation: Risk Profiles and Post‐Ablation Outcomes
Background: The clinical relevance of patient disease awareness on risk factor control and clinical outcomes after atrial fibrillation (AF) ablation remains incompletely understood. Methods: We conducted a prospective cohort study enrolling 133 patients undergoing an initial AF ablation. Disease awareness was assessed using the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) —a 16‐item instrument comprising 8 questions on general AF knowledge and 8 questions on oral anticoagulant therapy—administered before and 1 year after ablation. We divided them into the poor disease awareness group and good disease awareness group according to the median value (75%) of the JAKQ score about AF in general and compared the baseline patient characteristics and the 1‐year changes in the JAKQ score, blood pressure, laboratory data, echocardiographic parameters, and AF/atrial tachycardia (AT) recurrence rate between the groups. Results: Forty‐two (31.6%) patients were classified as having a poor disease awareness (< 75% of the JAKQ score about AF in general), which was associated with hypertension, diabetes, dyslipidemia, and greater left atrial volume (LAV). These trends in the poor disease awareness group remained unchanged 1 year after the ablation. During the 25.3 [15.7–34.9] month follow‐up, the AF/AT recurrence rate was significantly higher in the poor disease awareness than good disease awareness group (23.8% vs. 7.7%; p = 0.003 by the log‐rank test). Conclusions: Poor disease awareness was linked to lifestyle‐related diseases, greater LAV before and even 1 year after the ablation, making it a potential surrogate marker for AF/AT recurrence. These findings highlight the clinical significance of disease awareness for AF.
- 19 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Open AccessClinical Significance of Patient Disease Awareness in Atrial Fibrillation: Risk Profiles and Post‐Ablation Outcomes
Background: The clinical relevance of patient disease awareness on risk factor control and clinical outcomes after atrial fibrillation (AF) ablation remains incompletely understood. Methods: We conducted a prospective cohort study enrolling 133 patients undergoing an initial AF ablation. Disease awareness was assessed using the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) —a 16‐item instrument comprising 8 questions on general AF knowledge and 8 questions on oral anticoagulant therapy—administered before and 1 year after ablation. We divided them into the poor disease awareness group and good disease awareness group according to the median value (75%) of the JAKQ score about AF in general and compared the baseline patient characteristics and the 1‐year changes in the JAKQ score, blood pressure, laboratory data, echocardiographic parameters, and AF/atrial tachycardia (AT) recurrence rate between the groups. Results: Forty‐two (31.6%) patients were classified as having a poor disease awareness (< 75% of the JAKQ score about AF in general), which was associated with hypertension, diabetes, dyslipidemia, and greater left atrial volume (LAV). These trends in the poor disease awareness group remained unchanged 1 year after the ablation. During the 25.3 [15.7–34.9] month follow‐up, the AF/AT recurrence rate was significantly higher in the poor disease awareness than good disease awareness group (23.8% vs. 7.7%; p = 0.003 by the log‐rank test). Conclusions: Poor disease awareness was linked to lifestyle‐related diseases, greater LAV before and even 1 year after the ablation, making it a potential surrogate marker for AF/AT recurrence. These findings highlight the clinical significance of disease awareness for AF.
- 14 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (3) , 527-538
Precise Activation Within the Triangle of Koch: Insights from Ultra‐High‐Resolution Mapping and Cryoablation Terminating AVNRT
Background: Although slow pathway (SP) ablation is highly effective for atrioventricular nodal reentrant tachycardia (AVNRT), the detailed activation sequence and the functional significance of electrogram components within the triangle of Koch (ToK) remain unclear. Objective: To define the activation pattern within the ToK and clarify the mechanistic significance of sharp and dull potentials using ultra‐high‐resolution mapping and fractionated potential‐guided cryoablation. Methods: Thirty‐five patients with slow–fast AVNRT underwent ultra‐high‐resolution mapping during sinus rhythm (SR) and/or AVNRT using the RHYTHMIA‐system with LUMIPOINT tools. Propagation of sharp and dull potentials was analyzed by sliding the local activation window in 5‐ms increments. Cryoablation targeted fractionated potential sites where AVNRT terminated during cryomapping. Results: Two distinct electrogram components—sharp and dull potentials—were consistently identified in the mid‐to‐superior ToK. During SR, sharp potentials descended within the ToK, followed by dull potentials ascending toward and merging with His potentials. During AVNRT, ascending dull potentials preceded descending sharp potentials. Dull potentials were visualized with confidence levels ≥ 24% and consistently overlapped with sites causing transient atrioventricular block. Successful ablation sites were located immediately inferior to the dull‐potential region and corresponded to the fractionated potential area during AVNRT. AVNRT terminated during cryomapping in 25 of 30 patients (mean 13 ± 4 s). No recurrences were observed during follow‐up. Conclusion: Sharp and dull potentials represent distinct components of atrial activation and nodal–His transitional conduction. Fractionated potential‐guided cryoablation targeting early AVNRT termination enables safe and efficient ablation while avoiding injury to the nodal–His axis.
- 14 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (3) , 527-538
Precise Activation Within the Triangle of Koch: Insights from Ultra‐High‐Resolution Mapping and Cryoablation Terminating AVNRT
Background: Although slow pathway (SP) ablation is highly effective for atrioventricular nodal reentrant tachycardia (AVNRT), the detailed activation sequence and the functional significance of electrogram components within the triangle of Koch (ToK) remain unclear. Objective: To define the activation pattern within the ToK and clarify the mechanistic significance of sharp and dull potentials using ultra‐high‐resolution mapping and fractionated potential‐guided cryoablation. Methods: Thirty‐five patients with slow–fast AVNRT underwent ultra‐high‐resolution mapping during sinus rhythm (SR) and/or AVNRT using the RHYTHMIA‐system with LUMIPOINT tools. Propagation of sharp and dull potentials was analyzed by sliding the local activation window in 5‐ms increments. Cryoablation targeted fractionated potential sites where AVNRT terminated during cryomapping. Results: Two distinct electrogram components—sharp and dull potentials—were consistently identified in the mid‐to‐superior ToK. During SR, sharp potentials descended within the ToK, followed by dull potentials ascending toward and merging with His potentials. During AVNRT, ascending dull potentials preceded descending sharp potentials. Dull potentials were visualized with confidence levels ≥ 24% and consistently overlapped with sites causing transient atrioventricular block. Successful ablation sites were located immediately inferior to the dull‐potential region and corresponded to the fractionated potential area during AVNRT. AVNRT terminated during cryomapping in 25 of 30 patients (mean 13 ± 4 s). No recurrences were observed during follow‐up. Conclusion: Sharp and dull potentials represent distinct components of atrial activation and nodal–His transitional conduction. Fractionated potential‐guided cryoablation targeting early AVNRT termination enables safe and efficient ablation while avoiding injury to the nodal–His axis.
- Open Access
- 26 December 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (6)
Undiagnostic Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation Patients Undergoing Catheter Ablation
Background: Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist, but the prevalence of HFpEF among AF patients undergoing catheter ablation (CA) remains unclear. Methods: We studied 127 AF patients with preserved ejection fraction (≥ 50%) undergoing initial CA. The Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptides, Functional testing, and Final etiology (HFA‐PEFF) score was assessed 2 weeks before and 1 year after CA. Patients were grouped as low (0–1), intermediate (2–4), or high (5–6). The primary endpoint was AF freedom at 1 and 2 years; secondary endpoints were changes in HFA‐PEFF score; tertiary endpoint was predictors of score improvement. Results: Of 127 patients, 30 (23.6%) had HFpEF (score ≥ 5), 76 (59.8%) suspected (2–4), and 21 (16.5%) unlikely (≤ 1). Median follow‐up 24.4[ 12.5–29.5] months. AF freedom at 1 year was high (86.4%, 91.7%, 89.7%; p = 0.66). Higher baseline score correlated with older age, female sex, hypertension, larger left atrial volume index (LAVI), elevated average E / e ′, and increased left ventricular mass index. We divided patients into two groups: those with ≥ 1‐point score improvement after CA ( n = 89, 70.1%) and those whose score remained unchanged or worsened ( n = 38, 29.9%). Improvement was associated with older age, larger LAVI, higher average E / e ′, and elevated N‐terminal pro‐B‐type natriuretic peptide. Multivariate analysis identified septal e' and LAVI as predictors. No patients had a score ≥ 5 at 1 year. Conclusions: HFpEF or suspected HFpEF was common in AF CA candidates but not linked to recurrence. CA remarkably improved HFpEF features, suggesting reversibility.
- 26 December 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (6)
Open AccessUndiagnostic Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation Patients Undergoing Catheter Ablation
Background: Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist, but the prevalence of HFpEF among AF patients undergoing catheter ablation (CA) remains unclear. Methods: We studied 127 AF patients with preserved ejection fraction (≥ 50%) undergoing initial CA. The Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptides, Functional testing, and Final etiology (HFA‐PEFF) score was assessed 2 weeks before and 1 year after CA. Patients were grouped as low (0–1), intermediate (2–4), or high (5–6). The primary endpoint was AF freedom at 1 and 2 years; secondary endpoints were changes in HFA‐PEFF score; tertiary endpoint was predictors of score improvement. Results: Of 127 patients, 30 (23.6%) had HFpEF (score ≥ 5), 76 (59.8%) suspected (2–4), and 21 (16.5%) unlikely (≤ 1). Median follow‐up 24.4[ 12.5–29.5] months. AF freedom at 1 year was high (86.4%, 91.7%, 89.7%; p = 0.66). Higher baseline score correlated with older age, female sex, hypertension, larger left atrial volume index (LAVI), elevated average E / e ′, and increased left ventricular mass index. We divided patients into two groups: those with ≥ 1‐point score improvement after CA ( n = 89, 70.1%) and those whose score remained unchanged or worsened ( n = 38, 29.9%). Improvement was associated with older age, larger LAVI, higher average E / e ′, and elevated N‐terminal pro‐B‐type natriuretic peptide. Multivariate analysis identified septal e' and LAVI as predictors. No patients had a score ≥ 5 at 1 year. Conclusions: HFpEF or suspected HFpEF was common in AF CA candidates but not linked to recurrence. CA remarkably improved HFpEF features, suggesting reversibility.
- Open Access
- 26 November 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (2) , 221-231
First multicenter Japanese registry on tissue proximity-guided pulsed field ablation: Procedural safety and mid-term outcomes
- 26 November 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (2) , 221-231
Open AccessFirst multicenter Japanese registry on tissue proximity-guided pulsed field ablation: Procedural safety and mid-term outcomes
- Open Access
- 27 October 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (5)
Wall Thickness‐Guided vs. Voltage‐Guided Pulmonary Vein Isolation for Atrial Fibrillation
Background: The efficacy and safety of tailored pulmonary vein isolation (PVI) guided by either left atrial wall thickness (LAWT) or bipolar voltage remain unclear. Objective: The aim of this prospective study was to evaluate the efficacy and safety of each ablation strategy. Methods: We conducted a prospective analysis of 97 patients with non‐valvular atrial fibrillation (AF) who underwent an initial RF catheter ablation procedure known as an extensive encircling PVI. Fifty patients underwent PVI using a wall thickness (WT)‐guided approach using ADAS 3D software and 47 patients using a voltage‐guided approach. In each strategy, high‐power short‐duration (HPSD) ablation was applied to regions with increased LAWT or elevated bipolar voltage, respectively, while very high‐power short‐duration (vHPSD) ablation was delivered to the remaining regions. Results: The first‐pass PVI rate tended to be higher in the WT‐guided group compared to the Voltage‐guided group (43 [86%] vs. 34 [72%], p = 0.09), and the incidence of acute PV reconnection (APVR) tended to be lower (5 [10%] vs. 11 [23%], p = 0.07). The proportion of patients with PV gaps (defined as the combined occurrence of first‐pass failure and/or APVR) was significantly lower in the WT‐guided group (10 [20%] vs. 18 [38%], p = 0.04). The multivariable‐adjusted analysis demonstrated that WT‐guided ablation was significantly more effective than Voltage‐guided ablation in preventing PV gaps. Both ablation strategies were performed without any procedural complications. Conclusions: WT‐guided ablation was associated with a significantly lower incidence of PV gaps than a conventional bipolar voltage‐guided strategy.
- 27 October 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (5)
Open AccessWall Thickness‐Guided vs. Voltage‐Guided Pulmonary Vein Isolation for Atrial Fibrillation
Background: The efficacy and safety of tailored pulmonary vein isolation (PVI) guided by either left atrial wall thickness (LAWT) or bipolar voltage remain unclear. Objective: The aim of this prospective study was to evaluate the efficacy and safety of each ablation strategy. Methods: We conducted a prospective analysis of 97 patients with non‐valvular atrial fibrillation (AF) who underwent an initial RF catheter ablation procedure known as an extensive encircling PVI. Fifty patients underwent PVI using a wall thickness (WT)‐guided approach using ADAS 3D software and 47 patients using a voltage‐guided approach. In each strategy, high‐power short‐duration (HPSD) ablation was applied to regions with increased LAWT or elevated bipolar voltage, respectively, while very high‐power short‐duration (vHPSD) ablation was delivered to the remaining regions. Results: The first‐pass PVI rate tended to be higher in the WT‐guided group compared to the Voltage‐guided group (43 [86%] vs. 34 [72%], p = 0.09), and the incidence of acute PV reconnection (APVR) tended to be lower (5 [10%] vs. 11 [23%], p = 0.07). The proportion of patients with PV gaps (defined as the combined occurrence of first‐pass failure and/or APVR) was significantly lower in the WT‐guided group (10 [20%] vs. 18 [38%], p = 0.04). The multivariable‐adjusted analysis demonstrated that WT‐guided ablation was significantly more effective than Voltage‐guided ablation in preventing PV gaps. Both ablation strategies were performed without any procedural complications. Conclusions: WT‐guided ablation was associated with a significantly lower incidence of PV gaps than a conventional bipolar voltage‐guided strategy.
- Open Access
- 5 May 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (3) , e70083
Clinical insights into the role of bepridil in recurrence prevention after ablation of persistent atrial fibrillation
Background: The role of bepridil in preventing atrial fibrillation (AF) recurrence following ablation for persistent atrial fibrillation (PerAF) remains uncertain, particularly in patients with severe atrial substrates.Methods: This retrospective study included 232 consecutive PerAF patients who underwent AF ablation between 2014 and 2019. Among them, 162 received bepridil for 3 months post‐ablation (Bepridil group), while 70 received no antiarrhythmic drugs (No‐AADs group). Baseline characteristics, procedural details, and outcomes were compared. Kaplan–Meier analysis and Cox regression models were used to evaluate AF/atrial tachycardia (AT) recurrence, with bepridil use treated as a time‐dependent covariable.Results: The Bepridil group had a higher body mass index (25.1 ± 3.7 vs. 23.8 ± 3.9), a higher prevalence of patients with a LAD >40 mm and a LAV >50 mL (67.9% vs. 47.1%, 64.2% vs. 48.5%, respectively), and lower left atrial appendage flow velocity (37.6 ± 15.0 vs. 42.7 ± 20.5 cm/min). They more frequently underwent intracardiac atrial cardioversion (61.7% vs. 40.0%) and additional extra‐pulmonary vein ablation (35.2% vs. 15.7%), but were less likely to receive balloon‐based ablation (39.5% vs. 62.9%) (p < 0.05 for all comparison). During a median follow‐up of 23.3 months, AF/AT‐free survival at 2 years was comparable between the Bepridil and No‐AADs groups (80.4% vs. 81.7%; p = 0.61). This finding remained consistent after adjusting for baseline characteristics and considering bepridil as a time‐dependent covariable. No bepridil‐related adverse events occurred.Conclusion: Bepridil may have a limited role in preventing AF/AT recurrence in PerAF patients, particularly those with severe atrial substrates. However, its overall impact appears to be small, warranting further investigation.
- 5 May 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (3) , e70083
Open AccessClinical insights into the role of bepridil in recurrence prevention after ablation of persistent atrial fibrillation
Background: The role of bepridil in preventing atrial fibrillation (AF) recurrence following ablation for persistent atrial fibrillation (PerAF) remains uncertain, particularly in patients with severe atrial substrates.Methods: This retrospective study included 232 consecutive PerAF patients who underwent AF ablation between 2014 and 2019. Among them, 162 received bepridil for 3 months post‐ablation (Bepridil group), while 70 received no antiarrhythmic drugs (No‐AADs group). Baseline characteristics, procedural details, and outcomes were compared. Kaplan–Meier analysis and Cox regression models were used to evaluate AF/atrial tachycardia (AT) recurrence, with bepridil use treated as a time‐dependent covariable.Results: The Bepridil group had a higher body mass index (25.1 ± 3.7 vs. 23.8 ± 3.9), a higher prevalence of patients with a LAD >40 mm and a LAV >50 mL (67.9% vs. 47.1%, 64.2% vs. 48.5%, respectively), and lower left atrial appendage flow velocity (37.6 ± 15.0 vs. 42.7 ± 20.5 cm/min). They more frequently underwent intracardiac atrial cardioversion (61.7% vs. 40.0%) and additional extra‐pulmonary vein ablation (35.2% vs. 15.7%), but were less likely to receive balloon‐based ablation (39.5% vs. 62.9%) (p < 0.05 for all comparison). During a median follow‐up of 23.3 months, AF/AT‐free survival at 2 years was comparable between the Bepridil and No‐AADs groups (80.4% vs. 81.7%; p = 0.61). This finding remained consistent after adjusting for baseline characteristics and considering bepridil as a time‐dependent covariable. No bepridil‐related adverse events occurred.Conclusion: Bepridil may have a limited role in preventing AF/AT recurrence in PerAF patients, particularly those with severe atrial substrates. However, its overall impact appears to be small, warranting further investigation.
- Open Access
- 1 November 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (11)
Anatomical vs. electrophysiological approach for ablation of premature ventricular contractions originating from the left ventricular summit (ISESHIMA-SUMMIT Study)
Aims: Catheter ablation (CA) of idiopathic ventricular arrhythmias (VAs) from the epicardial left ventricular summit is challenging. The endocardial approach targets two sites: the endocardial closest site (ECS) to the epicardial earliest activation site (epi-EAS) and the endocardial earliest activation site (endo-EAS). We aimed to differentiate between cases where CA at the ECS was effective and where CA at the endo-EAS yielded success. Methods and results: Fifty-eight patients (47 men; age 60 ± 13 years) were analysed with VAs in which the EAS was observed in the coronary venous system (CVS). Overall, VAs were successfully eliminated in 42 (72%) patients: 8 in the CVS, 8 where the ECS matched with the endo-EAS, 11 at the ECS, and 15 at the endo-EAS. A successful ECS ablation was associated with a shorter epi-EAS–ECS distance (10.2 ± 4.7 vs. 18.8 ± 5.3 mm; P < 0.001) and shorter epi-EAS–left main coronary trunk (LMT) ostial distance (20.3 ± 7.6 vs. 30.3 ± 8.4 mm; P = 0.005), with optimal cut-off values of ≤12.6 and ≤24.0 mm, respectively. A successful endo-EAS ablation was associated with an earlier electrogram at the endo-EAS [23 (8, 36) vs. 15 (0, 19) ms preceding the QRS; P < 0.001] and shorter epi-EAS–endo-EAS interval [6 (1, 8) vs. 22 (12, 25) ms; P < 0.001], with optimal cut-off values of ≥18 and ≤9 ms, respectively. Conclusion: Shorter anatomical distances between the epi-EAS and ECS, and between the epi-EAS and LMT ostium, predict a successful ECS ablation. The prematurity of the endo-EAS electrogram and a shorter interval between the epi-EAS and endo-EAS predicted a successful endo-EAS ablation.
- 1 November 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (11)
Open AccessAnatomical vs. electrophysiological approach for ablation of premature ventricular contractions originating from the left ventricular summit (ISESHIMA-SUMMIT Study)
Aims: Catheter ablation (CA) of idiopathic ventricular arrhythmias (VAs) from the epicardial left ventricular summit is challenging. The endocardial approach targets two sites: the endocardial closest site (ECS) to the epicardial earliest activation site (epi-EAS) and the endocardial earliest activation site (endo-EAS). We aimed to differentiate between cases where CA at the ECS was effective and where CA at the endo-EAS yielded success. Methods and results: Fifty-eight patients (47 men; age 60 ± 13 years) were analysed with VAs in which the EAS was observed in the coronary venous system (CVS). Overall, VAs were successfully eliminated in 42 (72%) patients: 8 in the CVS, 8 where the ECS matched with the endo-EAS, 11 at the ECS, and 15 at the endo-EAS. A successful ECS ablation was associated with a shorter epi-EAS–ECS distance (10.2 ± 4.7 vs. 18.8 ± 5.3 mm; P < 0.001) and shorter epi-EAS–left main coronary trunk (LMT) ostial distance (20.3 ± 7.6 vs. 30.3 ± 8.4 mm; P = 0.005), with optimal cut-off values of ≤12.6 and ≤24.0 mm, respectively. A successful endo-EAS ablation was associated with an earlier electrogram at the endo-EAS [23 (8, 36) vs. 15 (0, 19) ms preceding the QRS; P < 0.001] and shorter epi-EAS–endo-EAS interval [6 (1, 8) vs. 22 (12, 25) ms; P < 0.001], with optimal cut-off values of ≥18 and ≤9 ms, respectively. Conclusion: Shorter anatomical distances between the epi-EAS and ECS, and between the epi-EAS and LMT ostium, predict a successful ECS ablation. The prematurity of the endo-EAS electrogram and a shorter interval between the epi-EAS and endo-EAS predicted a successful endo-EAS ablation.